BusinessETST and its wholly owned subsidiary, Cannabis Therapeutics, Signs Joint Venture with Smart Medicines GMP for the Development of its Cannabis Cannabinoid-Based Drugs & NutraceuticalsBy Nasdaq OMXFeb 14, 2017, 12:15 PM UTC
BusinessEarth Science Tech Strengthens Advisory Board with Four Distinguished Scientists and Doctors to Expand the Pharmaceutical & Nutraceutical Development of Cannabinoids' Therapeutic Indications, R&D, Technology, IP and TreatmentsBy Nasdaq OMXFeb 9, 2017, 12:45 PM UTC
BusinessEarth Science Tech Announces New Wholly Owned Subsidiary, Cannabis Therapeutics Inc., to Develop & Launch its Cannabis Cannabinoid-Based Drugs & Nutraceuticals Using its Cannabinoid-Cannabidiol (CBD) Patent, IP and TechnologyBy Nasdaq OMXFeb 6, 2017, 12:45 PM UTC
BusinessChineseInvestors.com Featured in New Interview with SmallCapVoice.comBy Nasdaq OMXFeb 1, 2017, 1:01 PM UTC
BusinessChineseInvestors.com Featured in New Interview with SmallCapVoice.comBy Nasdaq OMXFeb 1, 2017, 1:01 PM UTC
BusinessEarth Science Tech, Enters Multi-Billion Dollar Sports Supplement Industry via Joint Venture with Nutrition Specialties and ForzagenBy Nasdaq OMXJan 31, 2017, 12:45 PM UTC
BusinessKona Gold Solutions, Inc. to Produce all New Sugar Free Hemp Energy DrinkBy Nasdaq OMXJan 25, 2017, 2:00 PM UTC
BusinessEarth Science Tech, Inc. (OTC: ETST) Finalizes Joint Venture with Karmavore Superfoods and Signs New CMO, Sergio CastilloBy Nasdaq OMXJan 25, 2017, 12:45 PM UTC
